Key facts
- Lifeness’s last known valuation is $8.0M (Mar 2023).
- It has raised $2.9M; the latest was PE Growth/Expansion in May 2025.
- Notable investors include Farvatn Venture, Investinor, TGC Capital Partners, Arctic Accelerator, Arctic Investment Group — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Lifeness
- ·The full record, as it builds
Funding rounds
No funding rounds for Lifeness are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lifeness
Developer of a cloud-based medical platform designed to treat obesity and lifestyle diseases. The company's platform offers personalized therapy programs, AI-powered food recognition, mood tracking tools, and direct communication with healthcare professionals, enabling individuals with chronic illnesses and healthcare providers to improve health outcomes and maintain continuous care reliably.
- Sector
- Healthcare
- HQ
- Tromsø, Norway
- Founded
- 2018
- Employees
- 14
- Website
- lifeness.io/
- Ownership
- Privately Held (backing)
Lifeness doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lifeness shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lifeness in its N-PORT filings yet. We sweep new filings monthly.